APP and Alzheimer disease: Further, death-associated protein kinase 1 (DAPK1) is highly expressed in the AD brain and inhibition of DAPK1 was shown to decrease APP phosphorylation at Thr-668 and attenuate amyloidogenic processing of APP (Kim et al. 2016).